Early Endothelial Dysfunction in a Novel Model of Sustained Hyperphagia and Obesity in Mice Using a Brain Targeting Adeno-Associated Virus
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Galectin-3 Mediates Vascular Dysfunction in Obesity by Regulating NADPH Oxidase 1.
Padgett C, Batori R, Speese A, Rosewater C, Bush W, Derella C Arterioscler Thromb Vasc Biol. 2023; 43(10):e381-e395.
PMID: 37586054 PMC: 10695282. DOI: 10.1161/ATVBAHA.123.319476.
References
1.
Suleiman J, Mohamed M, Abu Bakar A
. A systematic review on different models of inducing obesity in animals: Advantages and limitations. J Adv Vet Anim Res. 2020; 7(1):103-114.
PMC: 7096124.
DOI: 10.5455/javar.2020.g399.
View
2.
Piche M, Tchernof A, Despres J
. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res. 2020; 126(11):1477-1500.
DOI: 10.1161/CIRCRESAHA.120.316101.
View
3.
Tao Y
. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev. 2010; 31(4):506-43.
PMC: 3365848.
DOI: 10.1210/er.2009-0037.
View
4.
Padgett C, Batori R, Speese A, Rosewater C, Bush W, Derella C
. Galectin-3 Mediates Vascular Dysfunction in Obesity by Regulating NADPH Oxidase 1. Arterioscler Thromb Vasc Biol. 2023; 43(10):e381-e395.
PMC: 10695282.
DOI: 10.1161/ATVBAHA.123.319476.
View
5.
Challis R, Kumar S, Chan K, Challis C, Beadle K, Jang M
. Systemic AAV vectors for widespread and targeted gene delivery in rodents. Nat Protoc. 2019; 14(2):379-414.
DOI: 10.1038/s41596-018-0097-3.
View